Document is current
Any future updates will be listed below
-
Authors
Othonos, Nantia http://orcid.org/0000-0002-9988-6328
Pofi, Riccardo http://orcid.org/0000-0001-7808-5735
Arvaniti, Anastasia
White, Sarah
Bonaventura, Ilaria
Nikolaou, Nikolaos http://orcid.org/0000-0002-8789-8436
Moolla, Ahmad
Marjot, Thomas
Stimson, Roland H. http://orcid.org/0000-0002-9002-6188
van Beek, André P. http://orcid.org/0000-0002-0335-8177
van Faassen, Martijn
Isidori, Andrea M.
Bateman, Elizabeth
Sadler, Ross
Karpe, Fredrik http://orcid.org/0000-0002-2751-1770
Stewart, Paul M.
Webster, Craig
Duffy, Joanne
Eastell, Richard
Gossiel, Fatma
Cornfield, Thomas
Hodson, Leanne
Jane Escott, K.
Whittaker, Andrew
Kirik, Ufuk
Coleman, Ruth L. http://orcid.org/0000-0002-5194-8550
Scott, Charles A. B.
Milton, Joanne E.
Agbaje, Olorunsola
Holman, Rury R. http://orcid.org/0000-0002-1256-874X
Tomlinson, Jeremy W. http://orcid.org/0000-0002-3170-8533
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N024591/1)
NIHR Oxford Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 31 July 2022
Accepted: 6 February 2023
First Online: 23 February 2023
Competing interests
: J.W.T. has been an advisory board member for Lumos, Pfizer AstraZeneca and Poxel. R.R.H. reports research support from AstraZeneca, Bayer and Merck Sharp & Dohme, and personal fees from Anji Pharmaceuticals, Novartis and Novo Nordisk. A.M.I. received consultation fees, unconditional grants and hospitality to conferences from IBSA, Takeda and IPSEN. R.E. receives consultancy funding from Immunodiagnostic Systems, Sandoz, Samsung, Haoma Medica, CL Bio, Biocon, Coherus, Takeda, meeting presentations for Pharmacosmos, Alexion and Amgen, and grant funding from Roche, Pharmacosmos and Alexion. A.W., K.J.E. and U.K. are full-time employees of AstraZeneca. The work has been supported by the NIHR Oxford Biomedical Research Centre. The remaining authors declare no other competing interests.
